122 related articles for article (PubMed ID: 1847777)
1. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
[No Abstract] [Full Text] [Related]
2. Synthesis and structure-activity relationships of a series of substituted-phenylpropionic acids as a novel class of leukotriene B4 antagonists.
Konno M; Sakuyama S; Nakae T; Hamanaka N; Miyamoto T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():411-4. PubMed ID: 1847779
[No Abstract] [Full Text] [Related]
3. Estimation of antagonistic activity of ONO-4057 against leukotriene B4 in humans.
Kishikawa K; Nakao S; Matsumoto S; Kondo K; Hamanaka N
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():279-81. PubMed ID: 7732853
[No Abstract] [Full Text] [Related]
4. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of the leukotriene B4 receptor by partial agonists.
Kiel D; Zipkin RE; Feinmark SJ
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():403-6. PubMed ID: 1847776
[No Abstract] [Full Text] [Related]
6. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.
Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH
Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
8. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate.
Hullot P; Poudrel JM; Muller A; Escale R; Rossi JC; Girard JP; Bonne C
Arzneimittelforschung; 1997 Jan; 47(1):51-8. PubMed ID: 9037445
[TBL] [Abstract][Full Text] [Related]
10. Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips.
Lawson CF; Wishka DG; Morris J; Fitzpatrick FA
J Lipid Mediat; 1989; 1(1):3-12. PubMed ID: 2562431
[TBL] [Abstract][Full Text] [Related]
11. 4-[2-[Methyl(2-phenethyl)amino]-2-oxoethyl]-8-(phenylmethoxy)-2- naphthalenecarboxylic acid: a high affinity, competitive, orally active leukotriene B4 receptor antagonist.
Huang FC; Chan WK; Warus JD; Morrissette MM; Moriarty KJ; Chang MN; Travis JJ; Mitchell LS; Nuss GW; Sutherland CA
J Med Chem; 1992 Oct; 35(22):4253-5. PubMed ID: 1331462
[No Abstract] [Full Text] [Related]
12. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
Lin AH; Morris J; Wishka DG; Gorman RR
Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene receptors.
Bray MA
Prog Clin Biol Res; 1985; 199():17-28. PubMed ID: 2999820
[No Abstract] [Full Text] [Related]
15. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist.
Djuric SW; Collins PW; Jones PH; Shone RL; Tsai BS; Fretland DJ; Butchko GM; Villani-Price D; Keith RH; Zemaitis JM
J Med Chem; 1989 Jun; 32(6):1145-7. PubMed ID: 2542550
[No Abstract] [Full Text] [Related]
16. Co-expression of leukotriene B4 and leukotriene D4 receptors on human monocytic leukemia U-937 cells.
Sarau HM; Mong S
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():180-6. PubMed ID: 2546381
[No Abstract] [Full Text] [Related]
17. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
Falcone RC; Aharony D
J Pharmacol Exp Ther; 1990 Nov; 255(2):565-71. PubMed ID: 2173748
[TBL] [Abstract][Full Text] [Related]
18. The role of leukotriene B4 as an inflammatory mediator in skin and the functional characterisation of LTB4 receptor antagonists.
Ekerdt R; Buchmann B; Fröhlich W; Giesen C; Heindl J; Skuballa W
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():565-8. PubMed ID: 1847567
[No Abstract] [Full Text] [Related]
19. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4.
Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ
J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936
[TBL] [Abstract][Full Text] [Related]
20. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus.
Gapinski DM; Mallett BE; Froelich LL; Jackson WT
J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
